Navigation Links
New Study Links Weed-Killer Glyphosate to Autism
Date:3/9/2017

LENEXA, Kan., March 8, 2017 /PRNewswire/ -- The peer-reviewed journal IMCJ (Integrative Medicine: A Clinician's Journal) just published a study by The Great Plains Laboratory, Inc. in the February/March 2017 issue indicating a connection between the herbicide glyphosate found in products such as Roundup™ and many other commercial herbicides (weed killers) and the presence of autism.  The World Health Organization International Agency for Research on Cancer published a summary in March 2015 that classified glyphosate as a probable carcinogen in humans.  The new study article is also available at www.PubMed.com.  

The complete title of the article is "Elevated Urinary Glyphosate and Clostridia Metabolites with Altered Dopamine Metabolism in Triplets with Autistic Spectrum Disorder or Suspected Seizure Disorder: A Case Study"and here is a link to that article:

The Great Plains Laboratory, Inc.
The Great Plains Laboratory, Inc.

https://www.greatplainslaboratory.com/articles-1/2017/2/13/elevated-urinary-glyphosate-and-clostridia-metabolites-with-altered-dopamine-metabolism-in-triplets-with-autistic-spectrum-disorder-or-suspected-seizure-disorder-a-case-study

William Shaw, Ph.D. of The Great Plains Laboratory, Inc in Lenexa, KS found very high amounts of glyphosate in urine samples of each of the triplets. The amount of glyphosate in the urine dropped dramatically after implementing a diet of only organic foods, with improvements noted in the functioning of the children. The two boys of the triplet set have autism while the girl of the triplet set had some other medical problems but does not have autism. The study's finding is significant because previous studies have shown that the rate of autism in the United States is highly correlated with the increased usage of glyphosate.

The study is also significant because it demonstrates a potential mechanism by which glyphosate could cause brain damage. People are exposed to high amounts of glyphosate when they consume genetically modified foods that are engineered to survive the toxicity of glyphosate. Weeds that are not genetically modified die when exposed to glyphosate.

It was previously thought that mammals, including humans that lack the enzymes that weeds possess would not be subject to glyphosate toxicity. However, recent research has found that glyphosate also kills beneficial bacteria in the environment and in the intestinal tracts of farm animals and humans. Glyphosate kills these beneficial bacteria by the same mechanism that it kills weeds. Pathogenic bacteria such as Clostridia and Salmonella lack the genes that kill the beneficial bacteria and proliferate in the soil and in the intestinal tract when glyphosate is present. This factor was of importance in the two boys of the triplets since both of them had elevated values of markers in the urine that indicated Clostridia overgrowth.  These markers may alter brain metabolism and brain development by the inhibition of the key brain enzyme dopamine-beta-hydroxylase, which is responsible for the conversion of dopamine to norepinephrine, important neurotransmitters in the brain (neurotransmitters are molecules that transmit signals or messages in the brain). This inhibition of dopamine-beta-hydroxylase leads to the overproduction of dopamine which may be toxic and cause brain damage at high concentrations. Some drugs used to treat autism like Risperdal™ block the effects of excessive dopamine.

If you have any questions, please don't hesitate to contact me or Dr. Shaw directly at wshaw@gpl4u.com

Heather Getz
Senior Marketing Representative
The Great Plains Laboratory, Inc.
11813 W. 77th St., Lenexa, KS 66214
Phone: 913-341-8949 x.159
Fax: 913-341-6207
www.GreatPlainsLaboratory.com

Related Files

Elevated Urinary Glyphosate.pdf

Related Links

Company Website

Link to Study Article

This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-study-links-weed-killer-glyphosate-to-autism-300420821.html


'/>"/>
SOURCE The Great Plains Laboratory, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Advocacy Study Highlights Top Locations for High-Growth Companies
2. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
3. New Study Shows Full Spectrum Endoscopy Procedure Reduces The Miss Rate of Adenomas During Colonoscopy
4. Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak
5. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
6. Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.
7. Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain
8. Ceregene Reports Additional Efficacy Data From Parkinsons Disease Phase 2b Study
9. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
10. Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency
11. Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & Associates ... special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to date ... elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded by ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
Breaking Medicine News(10 mins):